Document Detail


Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells.
MedLine Citation:
PMID:  19076167     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
1. Restenosis after percutaneous coronary intervention (PCI) is a major clinical complication. However, the underlying mechanisms remain poorly understood. The present aim of the present study was to test the hypothesis that reactive oxygen species (ROS) enhance osteopontin (OPN) expression and increase matrix metalloproteinase (MMP)-2 activity (two major factors that contribute to restenosis) in aortic vascular smooth muscle cells (VSMC), thus facilitating restenosis. 2. Primary cultured rat aortic VSMC were exposed to different concentrations (10, 50 and 100 micromol/L) of H(2)O(2). The expression of OPN mRNA and protein was determined by reverse transcription-polymerase chain reaction and Western blotting, respectively. The activity of MMP-2 was determined by gelatin zymography. 3. The expression of OPN mRNA and protein in VSMC was enhanced by H(2)O(2) in a dose-dependent manner. In addition, H(2)O(2) at all concentrations tested (which are comparable to those seen in diabetic vascular tissues) significantly increased MMP-2 activity in VSMC. 4. Because vascular ROS production is significantly increased in patients with ischaemic disease and OPN and MMP-2 have been shown to play critical role in restenosis, the results of the present study strongly suggest that a ROS-initiated and OPN- and MMP-2-mediated signalling pathway may play an important role in accelerated restenosis after PCI in patients with ischaemic disease. Therefore, the H(2)O(2)-OPN/MMP-2 system may be a new therapeutic target in reducing restenosis in patients undergoing PCI.
Authors:
Tao Hu; Ronghua Luan; Haifeng Zhang; Wayne B Lau; Qiong Wang; Yao Zhang; Hai-Chang Wang; Ling Tao
Related Documents :
10707367 - Overexpression of ets-1 transcription factor in angiosarcoma of the skin.
10432047 - Expression of metalloproteinases (mmp-1, mmp-2, and mmp-9) and their inhibitors (timp-1...
16314917 - A structure-activity study for the inhibition of metalloproteinase-9 activity and gene ...
11433397 - Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bik...
19347947 - Transcriptional activation of the beta-catenin gene at the invasion front of colorectal...
24520547 - Optimizing a novel method for low intensity ultrasound in chondrogenesis induction.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-11-28
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  36     ISSN:  1440-1681     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  626-30     Citation Subset:  IM    
Affiliation:
Deparrment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes.
Next Document:  Role of L-arginine in nitric oxide production in health and hypertension.